Medplus Health Services Ltd
₹ 688
0.41%
28 Mar
- close price
About
Key Points
- Market Cap ₹ 8,222 Cr.
- Current Price ₹ 688
- High / Low ₹ 978 / 598
- Stock P/E 140
- Book Value ₹ 127
- Dividend Yield 0.00 %
- ROCE 5.47 %
- ROE 3.26 %
- Face Value ₹ 2.00
Pros
- Company's working capital requirements have reduced from 85.3 days to 65.6 days
Cons
- Stock is trading at 5.40 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Tax rate seems low
- Company has a low return on equity of 6.36% over last 3 years.
- Promoters have pledged 58.0% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
1,368 | 1,733 | 2,011 | 2,131 | 2,273 | 2,871 | 3,069 | 3,779 | 4,558 | 5,387 | |
1,336 | 1,696 | 1,940 | 2,073 | 2,153 | 2,737 | 2,852 | 3,507 | 4,292 | 5,057 | |
Operating Profit | 32 | 37 | 71 | 58 | 120 | 134 | 217 | 273 | 266 | 330 |
OPM % | 2% | 2% | 4% | 3% | 5% | 5% | 7% | 7% | 6% | 6% |
4 | 8 | 7 | 8 | 11 | 17 | 21 | 31 | 46 | 43 | |
Interest | 14 | 17 | 19 | 28 | 50 | 47 | 55 | 66 | 83 | 94 |
Depreciation | 9 | 10 | 11 | 12 | 59 | 75 | 88 | 119 | 182 | 221 |
Profit before tax | 14 | 19 | 48 | 26 | 23 | 29 | 95 | 118 | 47 | 59 |
Tax % | 46% | 52% | 40% | -65% | 48% | 94% | 34% | 20% | -6% | |
7 | 9 | 29 | 42 | 12 | 2 | 63 | 95 | 50 | 59 | |
EPS in Rs | 419.34 | 508.71 | 1,620.57 | 2,080.06 | 585.46 | 107.02 | 1,393.11 | 8.03 | 4.17 | 4.92 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 16% |
3 Years: | 17% |
TTM: | 26% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 2% |
3 Years: | 197% |
TTM: | 70% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 8% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 6% |
3 Years: | 6% |
Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24 | 24 | 24 |
Reserves | 141 | 137 | 148 | 303 | 291 | 528 | 730 | 1,394 | 1,467 | 1,499 |
Preference Capital | 12 | 12 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | |
158 | 210 | 192 | 162 | 429 | 477 | 590 | 815 | 900 | 958 | |
139 | 162 | 196 | 179 | 239 | 344 | 245 | 361 | 406 | 457 | |
Total Liabilities | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 2,937 |
67 | 77 | 81 | 83 | 377 | 419 | 517 | 799 | 1,138 | 1,200 | |
CWIP | 3 | 3 | 2 | 1 | 1 | 5 | 6 | 20 | 25 | 9 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
368 | 429 | 453 | 560 | 580 | 924 | 1,043 | 1,775 | 1,633 | 1,729 | |
Total Assets | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 2,937 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|
-19 | -17 | 34 | 32 | 147 | -7 | 3 | 170 | 90 | |
-16 | -32 | -15 | -18 | -19 | -28 | -35 | -703 | 429 | |
67 | 35 | -29 | -1 | -83 | 90 | -6 | 440 | -170 | |
Net Cash Flow | 32 | -15 | -10 | 14 | 45 | 56 | -37 | -93 | 350 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 1 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 1 |
Inventory Days | 84 | 82 | 76 | 76 | 78 | 101 | 113 | 112 | 117 |
Days Payable | 34 | 29 | 25 | 27 | 31 | 37 | 22 | 30 | 27 |
Cash Conversion Cycle | 51 | 53 | 51 | 51 | 48 | 65 | 91 | 82 | 91 |
Working Capital Days | 42 | 41 | 39 | 39 | 31 | 45 | 69 | 121 | 66 |
ROCE % | 11% | 19% | 13% | 12% | 9% | 13% | 10% | 5% |
Documents
Announcements
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
1d - Subsidiary has received order from Assistant Director & Drug control Commission authority. The detailed disclosure is enclosed.
- Intimation Under Regulation 30 Read With Schedule III Of SEBI (LODR) Regulations, 2015 2d
- Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 26 Mar
- Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 26 Mar
- Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 26 Mar
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
India’s Leading Pharmacy company[1] MedPlus Health Services is the second-largest pharmacy retailer in India in terms of revenue and number of stores. The company has 4089 stores across the states of Telangana (679 stores), Andhra Pradesh (454 stores), Karnataka (893 stores), Tamil Nadu (845 stores), West Bengal (506 stores), Maharashtra (553 stores), and Odisha (149 stores), Chattisgarh (4 stores) Madhya Pradesh (4 stores) as of H1FY24.